Pharsight

Ani Pharms patents expiration

1. Atacand patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5196444

(Pediatric)

ANI PHARMS 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
Dec, 2012

(11 years ago)

US5534534 ANI PHARMS Pharmaceutical compositions for oral use and method of preparing them
Jul, 2013

(10 years ago)

US5534534

(Pediatric)

ANI PHARMS Pharmaceutical compositions for oral use and method of preparing them
Jan, 2014

(10 years ago)

Drugs and Companies using CANDESARTAN CILEXETIL ingredient

Market Authorisation Date: 04 June, 1998

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of ATACAND before it's drug patent expiration?
More Information on Dosage

ATACAND family patents

Family Patents

2. Atacand Hct patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5196444

(Pediatric)

ANI PHARMS 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
Dec, 2012

(11 years ago)

US5534534 ANI PHARMS Pharmaceutical compositions for oral use and method of preparing them
Jul, 2013

(10 years ago)

US5534534

(Pediatric)

ANI PHARMS Pharmaceutical compositions for oral use and method of preparing them
Jan, 2014

(10 years ago)

US5958961 ANI PHARMS Pharmaceutical composition for angiotensin II-mediated diseases
Jun, 2014

(10 years ago)

US5721263 ANI PHARMS Pharmaceutical composition for angiotensin II-mediated diseases
Feb, 2015

(9 years ago)

Drugs and Companies using CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE ingredient

Market Authorisation Date: 05 September, 2000

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

How can I launch a generic of ATACAND HCT before it's drug patent expiration?
More Information on Dosage

ATACAND HCT family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Innopran Xl patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500454 ANI PHARMS Timed, sustained release systems for propranolol
Oct, 2021

(2 years ago)

Drugs and Companies using PROPRANOLOL HYDROCHLORIDE ingredient

Market Authorisation Date: 12 March, 2003

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

INNOPRAN XL family patents

Family Patents

4. Veregen patents expiration

VEREGEN IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5968973 ANI PHARMS Method for treating hyperplasia
Apr, 2017

(7 years ago)

US5795911 ANI PHARMS Composition for treating Condyloma acuminata
Oct, 2020

(3 years ago)

US10434059 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Nov, 2022

(1 year, 6 months ago)

US9770406 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Jul, 2025

(1 year, 28 days from now)

US7858662 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Oct, 2026

(2 years from now)

Drugs and Companies using SINECATECHINS ingredient

Market Authorisation Date: 31 October, 2006

Treatment: Treatment of genital warts

Dosage: OINTMENT;TOPICAL

More Information on Dosage

VEREGEN family patents

Family Patents